Ann Arbor Pharmacometrics

A2PG, founded in 2007, is a leader in the field of pharmacometrics and model-informed drug development (MIDD). A2PG's expertise includes data management, population pharmacokinetics and exposure-response modeling, pediatric modeling and simulation, clinical trial simulation, and strategic consulting. A2PG scientists follow a team science approach, working as integrated members of client teams to implement model-based strategies and support critical decision-making. Over the past 15 years, A2PG has successfully supported over 200 BLA and NDA submissions in the United States and the European Union.